Sutro Biopharma (STRO) FCF Margin Growth (1y) (2018 - 2025)
Sutro Biopharma (STRO) FCF Margin Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sutro Biopharma |
252.04 Mn |
252.04 Mn |
- |
7,562.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
7,562.00 |
| Sep 30, 2025 |
38,514.00 |
| Jun 30, 2025 |
-12,329.00 |
| Mar 31, 2025 |
-71,040.00 |
| Dec 31, 2024 |
-48,997.00 |
| Sep 30, 2024 |
-56,551.00 |
| Jun 30, 2024 |
35,233.00 |
| Mar 31, 2024 |
-1,697.00 |
| Dec 31, 2023 |
36,164.00 |
| Sep 30, 2023 |
-48,385.00 |
| Jun 30, 2023 |
-27,584.00 |
| Mar 31, 2023 |
12,863.00 |
| Dec 31, 2022 |
-26,092.00 |
| Sep 30, 2022 |
69,027.00 |
| Jun 30, 2022 |
-636.00 |
| Mar 31, 2022 |
-38,901.00 |
| Dec 31, 2021 |
16,168.00 |
| Sep 30, 2021 |
-29,761.00 |
| Jun 30, 2021 |
12,233.00 |
| Mar 31, 2021 |
4,883.00 |
